Viral Vector Manufacturing Market Is Expected To Reach US$ 3,162.5 Million By 2027, Globally, At 25.40% CAGR

(MENAFN- EIN Presswire)

Viral Vector Manufacturing Market

The global viral vector manufacturing market size reached US$ 746.6 Million in 2021. By 2027, it will reach US$ 3,162.5 Million, CAGR of 25.40% (2022-2027).

SHERIDAN, WYOMING, USA, April 11, 2023 / / -- A viral vector is a tool deployed by molecular biologists to deliver genetic materials into cells. It is widely employed in cell and gene therapy to substitute defective genes for curing genetic disorders. It also expresses and presents pathogenic antigens by mimicking a natural infection for developing an immune response. In addition, it is used in treating various diseases, such as metabolic diseases, heart defects, neurodegenerative disorders, and oncolytic therapies to target and kill tumor cells. At present, viral vector manufacturing finds applications in gene therapy, life science research, and vaccinology across the globe.

Request a Free PDF Sample for more detailed market insights:

Viral Vector Manufacturing Market Trends and Drivers:

The market is primarily driven by the growing prevalence of chronic diseases such as genetic disorders, cancer, and infectious diseases. In addition, the increasing consumption of alcohol due to the sedentary lifestyles of individuals is contributing to the market growth. Moreover, as viral vectors are efficient carriers of virus-disabling sequences, they are widely used to provide HIV-inhibiting transgenes to human hematopoietic stem cells (HSCs), which represents another major growth-inducing factor.

Besides this, the increasing inclination toward clinical studies undertaken on viral vectors and the growing use of viral vectors in novel drug delivery is propelling the market growth. Along with this, governments are launching campaigns to create awareness regarding viral vector vaccines among individuals and improving the regulatory environment through changes that are accelerating the product adoption rate.

Furthermore, extensive research and development (R&D) activities and mergers and acquisitions (M&A) among key players to increase their overall sales and profitability are influencing the global market outlook.

Global Viral Vector Manufacturing Market 2022-2027 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Cognate BioServices Inc. (Charles River Laboratories International Inc.), F. Hoffmann-La Roche AG, FinVector Oy, FUJIFILM Holdings Corporation, Kaneka Eurogentec S.A. (Kaneka Corporation), Lonza Group AG, Merck KGaA, Oxford Biomedica plc, REGENXBIO Inc., Sanofi S.A., Thermo Fisher Scientific Inc. and uniQure N.V.

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure:

The report has segmented the market on the basis of region, type, disease, application and end user

Breakup by Type:
.Adenoviral Vectors
.Adeno-associated Viral Vectors
.Lentiviral Vectors
.Retroviral Vectors

Breakup by Disease:
.Genetic Disorders
.Infectious Diseases

Breakup by Application:
.Gene Therapy

Breakup by End User:
.Pharmaceutical and Biopharmaceutical Companies
.Research Institutes

Breakup by Region:
.North America: (United States, Canada)
.Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
.Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
.Latin America: (Brazil, Mexico, Others)
.Middle East and Africa

If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Key highlights of the report:
.Market Performance (2016-2021)
.Market Outlook (2022- 2027)
.Porter's Five Forces Analysis
.Market Drivers and Success Factors
.SWOT Analysis
.Value Chain
.Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Contact Us:

IMARC Services Private Limited.
134 N 4th St.
Brooklyn, NY 11249, USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Browse Other Reports:

hospital stretchers market Size 2022 | Research Report, Analysis, Trends, Opportunity by 2027

australia hair removal market to Reach US$ 1,131.8 Million by 2027 | Growth Rate (CAGR) 5.90% | IMARC Group

Pharmaceutical Robots Market :

Anand Ranjan
IMARC Services Private Limited
+1 631-791-1145
email us here


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.